Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|October 9, 2004
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomasGaspar Kitange, Anjan Misra, Mark Law, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 7, 2015
Modified aesthetic abdominoplasty approach in perforator free-flap breast reconstruction: Impact of drain free donor site on patient outcomesAnita T Mohan, Charalambos K Rammos, Prakriti Gaba, et al.
The Breast Journal|March 15, 2021
Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providersAnna Weiss, Victoria Cooley, Zahraa Al-Hilli, et al.
Annals of Surgery|August 27, 2010
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trialArmando E Giuliano, Linda McCall, Peter Beitsch, et al.
Annals of Surgery|August 12, 2016
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized TrialArmando E Giuliano, Karla Ballman, Linda McCall, et al.
Sarcoma|September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"Edwin Choy, Karla Ballman, James Chen, et al.
Journal of Neuropathology and Experimental Neurology|August 5, 2004
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significanceKenneth D Aldape, Karla Ballman, Alfred Furth, et al.
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Journal of Geriatric Oncology|May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trialEugenie Younger, Karla Ballman, Yao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.
Pageof 5